Crossmark

Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib

Published Online: 2018-02-07

Published Print: 2019-09-15

Authors

Kongsuphon, Noppadon

Soukavanitch, Maturos

Teeraaumpornpunt, Noramon

Konmun, Jitprapa

Ativitavas, Touch

Ngamphaiboon, Nuttapong https://orcid.org/0000-0002-6535-6345
License Information

Text and Data Mining valid from 2018-02-07

Version of Record valid from 2018-02-07
More Information

Article History

First Online: 7 February 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current